AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise. The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).
Learn more about the comment process
AMIA responses are arranged by Federal Agency and Congressional Committee.
AMIA joined the Friends of AHRQ to send a sign-on letter to Congress with over 190 signatories representing doctors, patients, researchers, health systems, and more, calling on them to fully fund AHRQ for FY26.
Funding AHRQ is critical for supporting health services research, implementing high value and accessible care, and […]
Led by Alliance for Connected Care, AMIA signed onto a letter to congratulate Pam Bondi on her appointment as U.S. Attorney General and urge her to rescind a proposed telehealth rule that restricts virtual prescribing of controlled substances. With temporary telehealth flexibilities ending in December 2025, millions risk losing critical […]
AMIA’s comments focused on enhancing internal coverage criteria, enhancing health equity analysis of the Prior Authorization (PA) tool, and guardrails for Artificial Intelligence (AI).
Read the full comments below.
AMIA submitted comments to the Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology (ASTP/ONC) USCDI+ Cancer – Clinical Trials Matching draft dataset use case.
On behalf of the signatories below, we thank you for your ongoing efforts to advance access to health care through telehealth. We write today to re-emphasize the importance of creating predictability by extending current telehealth flexibilities in an end-of-year package for a full year or more.
Both patients and practitioners […]
U.S. Department of Justice (DOJ) released a notice for proposed rulemaking (NPRM) regarding joint provisions on access to Americans’ bulk sensitive personal data and government-related data by countries of concern.
AMIA commented on (Coalition for Health AI) CHAI’s Assurance Standards Guide and Reporting Checklists and supports CHAI products to be the best they can be for consumer use. AMIA applauded the vast effort CHAI undertook to create this comprehensive document and the associated Checklist. Click the link below to read […]
With Alliance for Connected Care, AMIA joined alongside 340 organizations to urge Congress to extend telehealth flexibilities ensuring ongoing access to virtual prescribing for patients and providers. The coalition anticipates that the Drug Enforcement Administration (DEA) will dramatically limit virtual prescribing, either through new regulations or by allowing the existing […]
AMIA responds to Request for Information (RFI) on the National Institutes of Health (NIH) Draft
Public Access Policy. Areas AMIA commented on were embargo periods and publication costs, supplemental materials, and investigator rights. Read full comment letter below.